Radiopharm Theranostics Limited (‘RAD’) was admitted to the Official List of ASX on Tuesday, 23 November 2021.
The securities of RAD will commence quotation at 11:00AM AEDT on Thursday, 25 November 2021.
RAD raised $49,999,999.80 pursuant to the offer under its prospectus dated 14 October 2021 and supplementary prospectus dated 28 October 2021 by the issue of 83,333,333 shares at an issue price of $0.60 per share.
For more information, download the attached PDF.
Download this document
